Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

752
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
752

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Phenotyping antidepressant treatment response with deep learning in electronic health records.

Translational psychiatry·2026
Same author

Bacillus Calmette-Guérin (BCG) immunotherapy reprograms CNS immunity and alters Alzheimer's biomarkers: results from two open-label clinical trials.

Communications medicine·2026
Same author

Monitoring novel psychoactive substance trends on social media: Analysis of discussions and dashboard implementation.

Drug and alcohol dependence·2026
Same author

tRNA-derived fragments are elevated in the aging brain and may contribute to neurodegeneration.

bioRxiv : the preprint server for biology·2026
Same author

tRNA-derived fragments elevated in Alzheimer's disease facilitate Tau aggregation.

bioRxiv : the preprint server for biology·2026
Same author

Comparison of Fluorescent Probes for IDH-Wildtype Glioblastoma, Metastatic Brain Tumors, and PCNSL: A Biomechanical Perspective.

International journal of molecular sciences·2026

相关实验视频

Updated: Jan 9, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.7K

开发用于阿尔茨海默病的血蛋白分类模型,使用多种机器学习方法.

Amy Tsurumi1, Catherine M Cahill2, Andy J Liu3,4

  • 1Department of Surgery, Massachusetts General Hospital and Harvard Medical School, 55 Fruit St., Boston, MA 02114, USA.

International journal of molecular sciences
|December 11, 2025
PubMed
概括

新阿尔茨海默病 (AD) 检测使用血生物标志物和机器学习进行准确,非侵入性诊断. 已识别的蛋白质,如ANG-2和EGF,对早期检测和潜在的治疗有很大的前景.

关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.老化的老化 衰老的老化生物标志物 生物标志物诊断 诊断 诊断 诊断 诊断 诊断机器学习是机器学习.神经退行症的神经退行症蛋白质组学 蛋白质组学

更多相关视频

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

8.2K

相关实验视频

Last Updated: Jan 9, 2026

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.7K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

8.2K

科学领域:

  • 神经科学是一个神经科学.
  • 生物标志物发现发现
  • 计算生物学 计算生物学

背景情况:

  • 阿尔茨海默病 (AD) 诊断依赖于侵入性脑脊液 (CSF) 生物标志物,导致患者的不适.
  • 当前检测方法的局限性对有效的AD管理提出了挑战.
  • 基于等离子体的生物标志物提供了一个不那么侵入性的,更具成本效益的诊断替代品.

研究的目的:

  • 开发和验证用于使用血蛋白质组数据检测AD的机器学习模型.
  • 确定与阿尔茨海默病相关的新型血蛋白生物标志物.
  • 探索已识别的生物标志物在AD病原和衰老中的相关性.

主要方法:

  • 利用了来自AD患者和认知正常个体的120个血蛋白的数据集.
  • 应用各种机器学习算法 (EBlasso,EBEN,XGBoost,LightGBM,TabNet,TabPFN) 来进行分类.
  • 进行了基因本体学,途径丰富和文献审查,以评估生物标志物的相关性.

主要成果:

  • 机器学习模型实现了高诊断性能 (AUROC和精度>0.9).
  • 一贯识别的预测蛋白包括angiopoietin-2 (ANG-2),EGF,IL-1α和PDGF-BB,它们与AD有已确定的联系.
  • 识别的生物标志物池被与衰老相关的蛋白质显著丰富 (p=0.040).

结论:

  • 尖端算法增强了基于等离子体的AD预测模型的开发.
  • 这些已识别的蛋白质可能成为阿尔茨海默病的新型治疗或预防点.
  • 在不同人群中进行外部验证至关重要,以确认这些发现的概括性.